Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
A rapid and automated method for discovering potential drugs for the treatment of sickle cell anemia, using a combination of laser photolysis and statistical processing of digital images. More
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms More
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Increasing the stability and improving the reconstitution of biomolecules using supercritical fluid (SCF) processing More
Crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Related Reports
Market Research Reports provided by reports.innovaro.com
Aug 2011 - 6 pages - $500
Feb 2011 - 129 pages - $500
Aug 2008 - 120 pages - $1,040
Nov 2010 - 738 pages - $1,495
Nov 2010 - 50 pages - $500
May 2011 - 38 pages - $500
Dec 2010 - 36 pages - $500
Jan 2009 - $15,200
Nov 2010 - 55 pages - $2,000
Aug 2011 - 113 pages - $3,500
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Anemia (other)
- Anemia, erythropoetin tx
- Anemia, sickle cell
- Hemolytic anemia
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us